Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer
Status:
Terminated
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The study is to evaluate the R0 resection rate of patients with unresectable locally advanced
pancreatic cancer ,after treated with S-1 plus Paclitaxel-albumin as neoadjuvant chemotherapy
protocols